R E Wolf Selected Research

R E Wolf Research Topics

3	Hypoxia (Hypoxemia) 01/2001 - 02/2000
2	Neoplasms (Cancer) 12/2014 - 01/2000
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2014
1	Ischemia 12/2001
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2001
1	Thrombosis (Thrombus) 10/2001
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2001
1	Infections 02/2000
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2000
1	Rheumatoid Arthritis 01/2000
1	Arthritis (Polyarthritis) 01/2000
1	Margins of Excision 01/2000
1	Inflammation (Inflammations) 01/2000

1	Particulate MatterIBA 12/2014
1	Heparin (Liquaemin)FDA LinkGeneric 10/2001
1	Immunoglobulin A (IgA)IBA 10/2001
1	Immunoglobulin G (IgG)IBA 10/2001
1	Warfarin (Coumadin)FDA LinkGeneric 10/2001
1	AnticoagulantsIBA 10/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2001
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2001
1	MyoglobinIBA 07/2001
1	Oxygen (Dioxygen)IBA 07/2001
1	3-nitrotyrosineIBA 07/2001
1	NF-kappa B (NF-kB)IBA 01/2001
1	Transcription Factors (Transcription Factor)IBA 01/2001
1	Cell Adhesion MoleculesIBA 06/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2000
1	EndosulfanIBA 02/2000
1	DDTIBA 02/2000
1	DieldrinIBA 02/2000
1	Polychlorinated Biphenyls (PCBs)IBA 02/2000
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2000
1	Biological ProductsIBA 01/2000
1	Polysaccharides (Glycans)IBA 01/2000
1	Peptidoglycan (Murein)IBA 01/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2000
1	Interleukin-6 (Interleukin 6)IBA 01/2000
1	CytokinesIBA 01/2000

2	Therapeutics 10/2001 - 01/2000
1	Liver Transplantation 12/2001
1	Transplantation 12/2001
1	Intraperitoneal Injections 01/2000